Michelson Medical Research Foundation Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$5.11M |
| 2 |
iShares Micro-Cap ETF
IWC
|
+$3.83M |
| 3 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$3.77M |
| 4 |
iShares MSCI Mexico ETF
EWW
|
+$2.59M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 11.76% |
| 2 | Energy | 5.09% |
Similar funds
Michelson Medical Research Foundation's Q3 2023 Portfolio in Review
As of Q3 2023, Michelson Medical Research Foundation held 28 positions worth $148M, up 5.4% from $141M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Michelson Medical Research Foundation deployed $12.2M of net new capital in Q3 2023, opening 8 new positions and adding to 1 existing holding. Its largest new stake was State Street SPDR S&P Regional Banking ETF: 114,700 shares worth $4.79M.
By sector, the portfolio is most concentrated in Real Estate at 12% of assets, down from 14% a quarter earlier, followed by Energy.
On the sell side, the most notable exit was iShares 0-3 Month Treasury Bond ETF, an estimated $12M sold.
- Michelson Medical Research Foundation's largest Q3 2023 buy was State Street SPDR S&P Regional Banking ETF: 114,700 shares worth $4.79M.
- Michelson Medical Research Foundation added most to Vanguard FTSE Developed Markets ETF in Q3 2023, an estimated $2.53M increase.
- Michelson Medical Research Foundation fully exited iShares 0-3 Month Treasury Bond ETF in Q3 2023, selling an estimated $12M.
- Michelson Medical Research Foundation's ten largest holdings make up 71% of its $148M portfolio in Q3 2023.
- Michelson Medical Research Foundation opened 8 new positions and closed 1 in Q3 2023.
- Michelson Medical Research Foundation's portfolio value rose 5.4% quarter-over-quarter to $148M.
Based on Michelson Medical Research Foundation's 13F filing for Q3 2023, filed 14 Nov 2023.